|
1
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Tran I, Seshareddy K, Weiss ML and
Detamore MS: A comparison of human bone marrow-derived mesenchymal
stem cells and human umbilical cord-derived mesenchymal stromal
cells for cartilage tissue engineering. Tissue Eng Part A.
15:2259–2266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hombauer H and Minguell JJ: Selective
interactions between epithelial tumour cells and bone marrow
mesenchymal stem cells. Br J Cancer. 82:1290–1296. 2000. View Article : Google Scholar
|
|
4
|
Liu H, Zang C, Fenner MH, Possinger K and
Elstner E: PPARgamma ligands and ATRA inhibit the invasion of human
breast cancer cells in vitro. Breast Cancer Res Treat. 79:63–74.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magenta G, Borenstein X, Rolando R and
Jasnis MA: Rosiglitazone inhibits metastasis development of a
murine mammary tumor cell line LMM3. BMC Cancer. 8:472008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Adams J, Carder PJ, Downey S, Forbes MA,
MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ,
et al: Vascular endothelial growth factor (VEGF) in breast cancer:
Comparison of plasma, serum and tissue VEGF and microvessel density
and effects of tamoxifen. Cancer Res. 60:2898–2905. 2000.PubMed/NCBI
|
|
7
|
Robinson SC, Scott KA, Wilson JL, Thompson
RG, Proudfoot AE and Balkwill FR: A chemokine receptor antagonist
inhibits experimental breast tumor growth. Cancer Res.
63:8360–8365. 2003.PubMed/NCBI
|
|
8
|
Yaal-Hahoshen N, Shina S, Leider-Trejo L,
Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I and
Ben-Baruch A: The chemokine CCL5 as a potential prognostic factor
predicting disease progression in stage II breast cancer patients.
Clin Cancer Res. 12:4474–4480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vaday GG, Peehl DM, Kadam PA and Lawrence
DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Prostate. 66:124–134. 2006. View Article : Google Scholar
|
|
10
|
Loberg RD, Ying C, Craig M, Yan L, Snyder
LA and Pienta KJ: CCL2 as an important mediator of prostate cancer
growth in vivo through the regulation of macrophage infiltration.
Neoplasia. 9:556–562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghosh S, Sullivan CA, Zerkowski MP,
Molinaro AM, Rimm DL, Camp RL and Chung GG: High levels of vascular
endothelial growth factor and its receptors (VEGFR-1, VEGFR-2,
neuropilin-1) are associated with worse outcome in breast cancer.
Hum Pathol. 39:1835–1843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stacey DL, Gibala MJ, Martin-Ginis KA and
Timmons BW: Effects of recovery method after exercise on
performance, immune changes and psychological outcomes. J Orthop
Sports Phys Ther. 40:656–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hartmann MC, Dwyer RM, Costello M, Potter
SM, Curran C, Hennessy E, Newell J, Griffin DG and Kerin MJ:
Relationship between CCL5 and transforming growth factor-β1 (TGFβ1)
in breast cancer. Eur J Cancer. 47:1669–1675. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Ginestier C, Ou SJ, Clouthier SG,
Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, et
al: Breast cancer stem cells are regulated by mesenchymal stem
cells through cytokine networks. Cancer Res. 71:614–624. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Galland F, Stefanova M, Lafage M and
Birnbaum D: Localization of the 5′ end of the MCF2 oncogene to
human chromosome 15q15-q23. Cytogenet Cell Genet. 60:114–116. 1992.
View Article : Google Scholar
|
|
16
|
Wang P, Branch DR, Bali M, Schultz GA,
Goss PE and Jin T: The POU homeodomain protein OCT3 as a potential
transcriptional activator for fibroblast growth factor-4 (FGF-4) in
human breast cancer cells. Biochem J. 375:199–205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamb KA and Rizzino A: Effects of
differentiation on the transcriptional regulation of the FGF-4
gene: Critical roles played by a distal enhancer. Mol Reprod Dev.
51:218–224. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boiani M and Schöler HR: Regulatory
networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell
Biol. 6:872–884. 2005. View
Article : Google Scholar : PubMed/NCBI
|
